Shares of Tonix Pharmaceuticals (TNXP) plunged Monday after the company announced its lead drug candidate came up short of the primary goal in a mid-stage trial.
Full Answer
How often do you update the TNXP stock prediction?
"TNXP" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "TNXP" projections. At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Tonix Pharmaceuticals Holding Corp.
Where can I buy shares of TNXP?
Shares of TNXP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is Tonix (TNXP) out of the ballgame?
However, TNXP stock isn't quite out of the ballgame yet. In fact, the stock has leapt back onto traders' radars over the past month thanks to a recently announced share buyback. Zooming in on the above chart, we can see that Tonix jumped from $2 to $3 for a brief moment at the end of May.
Will Tonix Pharmaceuticals (TNXP) outperform or underperform the S&P 500 over the long term?
Vote “Outperform” if you believe TNXP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TNXP will underperform the S&P 500 over the long term. You may vote once every thirty days. Tonix Pharmaceuticals does not currently pay a dividend. Tonix Pharmaceuticals does not have a long track record of dividend growth.
What is TNXP NASDAQ?
What is TNX 102?
When will Tonix be added to the Russell 3000?
About this website
Why did TNXP stock fall?
After scoring two promising FDA designations on its lead drug, tiny Tonix Pharmaceuticals is aborting its late-stage study in PTSD due to lousy results — nearly flat-lining the company's stock Friday morning.
Is TNXP a good investment?
On average, analysts forecast that TNXP's EPS will be -$6.25 for 2022, with the lowest EPS forecast at -$6.39, and the highest EPS forecast at -$6.12. On average, analysts forecast that TNXP's EPS will be -$6.73 for 2023, with the lowest EPS forecast at -$7.99, and the highest EPS forecast at -$5.48.
What is the future of TNXP?
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) The 2 analysts offering 12-month price forecasts for Tonix Pharmaceuticals Holding Corp have a median target of 53.00, with a high estimate of 96.00 and a low estimate of 10.00. The median estimate represents a +2,072.13% increase from the last price of 2.44.
Did TNXP reverse split?
(Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it will effect a 1-for-32 reverse stock split of its outstanding common stock. This will be effective for trading purposes as of the commencement of trading on May 17, 2022.
Will TNXP be delisted?
The Company's common stock was transferred to the Nasdaq Capital Market effective as of March 3, 2022, and will continue to trade under the symbol “TNXP.” The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, but with less stringent listing requirements, although listed ...
Is Castor Maritime a good stock to buy?
If you are looking for stocks with good return, Castor Maritime Inc can be a profitable investment option. Castor Maritime Inc quote is equal to 1.490 USD at 2022-06-21. Based on our forecasts, a long-term increase is expected, the "CTRM" stock price prognosis for 2027-06-11 is 2.114 USD.
Will TXMD stock go up?
Stock Price Forecast The 2 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 5.50, with a high estimate of 10.00 and a low estimate of 1.00. The median estimate represents a -44.33% decrease from the last price of 9.88.
How many employees does Tonix Pharma have?
Compare TNXP With Other StocksTonix Pharmaceuticals Holding Annual Number of Employees2021732020262019162018129 more rows
Will CEI stock go up?
Based on the algorithm-based CEI price prediction from Wallet Investor as of 22 March, the price of Camber Energy in the near term could rise to $1.14 per share by 4 April 2022.
What does a 1 for 4 reverse stock split mean?
For example, in a 1:4 reverse split, the company would provide one new share for every four old shares. So if you owned 100 shares of a $10 stock and the company announced a 1:4 reverse split, you would own 25 shares trading at $40 per share.
What is a reverse split on stocks?
When a company completes a reverse stock split, each outstanding share of the company is converted into a fraction of a share. For example, if a company declares a one for ten reverse stock split, every ten shares that you own will be converted into a single share.
TNXP Tonix Pharmaceuticals Holding Corp — Stock Price and Discussion ...
Real-time trade and investing ideas on Tonix Pharmaceuticals Holding Corp TNXP from the largest community of traders and investors.
Premarket Movers & News • Benzinga
PreMarket trading coverage for US stocks including news, movers, losers and gainers, upcoming earnings, analyst ratings, economic calendars and futures.
Bionano Genomics, Inc. (BNGO) Stock Price, News, Quote & History ...
Find the latest Bionano Genomics, Inc. (BNGO) stock quote, history, news and other vital information to help you with your stock trading and investing.
Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Tonix Pharmaceuticals Holding Corp.
Support, Risk & Stop-loss
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
Is Tonix Pharmaceuticals Holding Corp. stock A Buy?
Tonix Pharmaceuticals Holding Corp. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Insiders are very positive buying more shares than they are selling in Tonix Pharmaceuticals Holding Corp
In the last 100 trades there were 20.56 million shares bought and 10 thousand shares sold. The last trade was done 8 days ago by Lederman Seth who bough 5 million shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
About Tonix Pharmaceuticals Holding Corp
Tonix Pharmaceuticals Holding Corp. engages in developing medicines for common disorders of the central nervous system. These disorders are characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden.
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
NASDAQ: TNXP
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
What happened
Shares of Tonix Pharmaceuticals ( TNXP -6.38% ) were crashing 28.3% lower as of 10:24 a.m. EDT on Monday. The big decline came after Tonix announced on Friday following the market close that it is halting enrollment in a late-stage clinical study evaluating TNX-102 SL in treating fibromyalgia.
So what
Tonix made the decision to stop enrollment in its late-stage study of TNX-102 SL after the study's Independent Data Monitoring Committee (IDMC) completed an interim analysis.
NASDAQ: TNXP
TNX-102 SL is Tonix's lead pipeline candidate. In addition to being evaluated in treating fibromyalgia, the company also has hopes for the drug in treating post-traumatic stress disorder-related sleep disturbance, agitation in patients with Alzheimer's disease, and alcohol use disorder.
Now what
What's next for the biotech company? Tonix isn't throwing in the towel on TNX-102 SL in fibromyalgia yet. The company plans to move forward with its late-stage study targeting fibromyalgia with the patients who are already enrolled.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
What is TNXP NASDAQ?
By David Bautz, PhD NASDAQ:TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Tonix Pharmaceutical Holdings Corp. (NASDAQ:TNXP) has undergone a transformation over the past year as it has built up a robust pipeline of clinical stage assets focused on the treatment of central nervous system (CNS) and immunological diseases. In addition, the company’s balance sheet has never been stronger. As
What is TNX 102?
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) plans to develop TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for Long COVID Syndrome (Long COVID), which is now known officially as Post-Acute Sequelae of COVID-19 (PASC1). Tonix plans to meet the FDA in Q3 of 2021 to seek agreement on designing a potential Phase 2 study and the overall clinical development plan. TNX-102 SL is in the second Phase 3 trial (RALLY) for fibromyalgia. The interim analysis results are expected in Q3 of 2021, an
When will Tonix be added to the Russell 3000?
CHATHAM, N.J., June 28, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Tonix was added to the broad-market Russell 3000® index and the small-cap Russell 2000® Index, effective after the U.S. market opens today, June 28, 2021, as part of the annual reconstitution of the Russell stock indexes. "Tonix is pleased to be included in the Russell indexes which reflects our positive achie
ATOS (DD) - The Next Gamma Storm
Hello r/pennystocks. I have a history of posting to r/wallstreetbets but this is my first post here, as the ticker in question has a market cap of <$1B. I’ve taken the time to put together this DD but would appreciate any critical commentary if you see something I’m missing.
High Tide added to the THCX ETF
CALGARY, May 18, 2021 /CNW/ – High Tide Inc. (“High Tide” or the “Company”) (TSXV: HITI) (OTCQB: HITID) (FRA:2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, is pleased to announce today that it has been added to the Cannabis ETF (NYSE: THCX) (the “THCX”).
What is TNXP NASDAQ?
By David Bautz, PhD NASDAQ:TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Tonix Pharmaceutical Holdings Corp. (NASDAQ:TNXP) has undergone a transformation over the past year as it has built up a robust pipeline of clinical stage assets focused on the treatment of central nervous system (CNS) and immunological diseases. In addition, the company’s balance sheet has never been stronger. As
What is TNX 102?
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) plans to develop TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for Long COVID Syndrome (Long COVID), which is now known officially as Post-Acute Sequelae of COVID-19 (PASC1). Tonix plans to meet the FDA in Q3 of 2021 to seek agreement on designing a potential Phase 2 study and the overall clinical development plan. TNX-102 SL is in the second Phase 3 trial (RALLY) for fibromyalgia. The interim analysis results are expected in Q3 of 2021, an
When will Tonix be added to the Russell 3000?
CHATHAM, N.J., June 28, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Tonix was added to the broad-market Russell 3000® index and the small-cap Russell 2000® Index, effective after the U.S. market opens today, June 28, 2021, as part of the annual reconstitution of the Russell stock indexes. "Tonix is pleased to be included in the Russell indexes which reflects our positive achie
